Home
NSE: ORCHPHARMA
Market Cap
NSE: ORCHPHARMA
Share Price
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
14 Jan 2025 | 1647 | 1665 | 1689.2 | 1640.15 |
13 Jan 2025 | 1673.65 | 1844.8 | 1844.8 | 1658.05 |
10 Jan 2025 | 1845.95 | 1872.25 | 1883.1 | 1812 |
09 Jan 2025 | 1884.75 | 1914.75 | 1914.75 | 1841.05 |
08 Jan 2025 | 1877.2 | 1880.65 | 1900 | 1841 |
07 Jan 2025 | 1881.1 | 1864.7 | 1901.95 | 1846.7 |
06 Jan 2025 | 1864.7 | 1932.75 | 1988.95 | 1797.05 |
03 Jan 2025 | 1982.8 | 1873.75 | 1998 | 1873.75 |
02 Jan 2025 | 1868.35 | 1874.75 | 1881.5 | 1820.05 |
01 Jan 2025 | 1829.25 | 1807 | 1843.95 | 1807 |
Date | Price (₹) |
---|---|
14 Jan 2025 | 1647 |
13 Jan 2025 | 1673.65 |
10 Jan 2025 | 1845.95 |
09 Jan 2025 | 1884.75 |
08 Jan 2025 | 1877.2 |
07 Jan 2025 | 1881.1 |
06 Jan 2025 | 1864.7 |
03 Jan 2025 | 1982.8 |
02 Jan 2025 | 1868.35 |
01 Jan 2025 | 1829.25 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical P/E Ratio of Orchid Pharma Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical Revenue of Orchid Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical EBITDA of Orchid Pharma Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical Net Profit of Orchid Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Net profit of Orchid Pharma rose 212.23% to Rs 29.35 crore in the quarter ended June 2024 as against
Read more
2024-08-13 00:00:00
Orchid Pharma will hold a meeting of the Board of Directors of the Company on 12 August 2024. Powere
Read more
2024-08-10 00:00:00
Orchid Pharma will hold a meeting of the Board of Directors of the Company on 11 November 2024 Power
Read more
2024-11-06 00:00:00
Net profit of Orchid Pharma rose 37.58% to Rs 27.24 crore in the quarter ended September 2024 as aga
Read more
2024-11-11 00:00:00